For example, we identified pathways related to adiponectin signaling in cancer cells [13], cell proliferation, and/or survival as well as the pathways involved in glucose signaling and specifically dysregulated in hepatocellular carcinoma [14,15]. Here, ADIPOQ is linked to cancer.